Pharmafile Logo

payer survey

- PMLiVE

Global Health Beat – Spain

On the Global Health Beat, Matthew Durham, our Director of Global Media; Juan Pedro Franco, General Director, Fidia Pharmaceuticals, and Fernando Rojas, Director Health and Life Sciences, SNGULAR, capture the...

CMI Media Group

- PMLiVE

PM360 – A Year in Review

It’s been a little over a year since we expanded globally, and in a new article for PM360, Matt Durham, Director, Global Media, shares the insights from that experience –...

CMI Media Group

- PMLiVE

PM360 – Transitioning to Omnidynamic in Europe

Omnichannel marketing has been adopted in the US but is needed in the EU as well, as this new article by our Global Media Director Matt Durham shares. Read more here!

CMI Media Group

Financial Times – Doceree Launches HIEP to Unveil the Untapped Potential of Healthcare Digital Platforms

As seen in the Financial Times, Doceree, the leading global healthcare marketing platform building unprecedented programmatic solutions for HCP marketing, announced the launch of its highly anticipated HIEP (High Interaction & Engagement...

CMI Media Group

CMI Media Group Expands Globally with London Office; Hires Matt Durham as Global Director

CMI Media Group Expands Globally with London Office; Hires Matt Durham as Global Director

CMI Media Group

- PMLiVE

Getting in-sync with Public Health at SYNC 2024

Medscape Education is bringing its public health efforts to Washington, DC for the SYNC conference on HIV, HCV, STIs, Harm Reduction, and LGBTQ health. During the conference, Lindsey will present...

Medscape Education Global

- PMLiVE

Disconnected pharma: Navigating digital challenges and priorities in 2024

We are delighted to present Graphite’s research whitepaper for 2024 — and this year we are able to share the challenges and priorities that digital leaders are finding, in this...

Graphite Digital

- PMLiVE

Health literacy – levelling the playing field

In health, there is freedom. - Henri Frederic Amiel. Our health can powerfully shift the course of our lives. And so it follows that autonomy over our health should be...

Wallace Health

EU flag

EC approves Celltrion’s omalizumab biosimilar Omlyclo for immunological conditions

The drug can be used to treat patients with conditions including chronic spontaneous urticaria

- PMLiVE

Novartis shares positive late-stage results for Fabhalta in rare kidney disease C3 glomerulopathy

Approximately one to two people per million worldwide are diagnosed with C3G every year

- PMLiVE

Study reveals inflammation caused by infections could contribute to MS progression

The progressive, neurodegenerative disease is estimated to affect more than 130,000 people in the UK

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links